Valuation: Biogen Inc.

Market Cap 36.9B 33.05B 30.49B 27.6B 51.6B 3,514B 52.44B 364B 145B 1,839B 138B 136B 5,825B P/E 2026 *
45.8x
P/E 2027 * 22.4x
Enterprise Value 42.61B 38.16B 35.21B 31.86B 59.57B 4,057B 60.54B 420B 168B 2,123B 160B 156B 6,725B EV / Sales 2026 *
4.1x
EV / Sales 2027 * 3.79x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day+2.29%
1 week-1.65%
Current month+10.52%
1 month+9.94%
3 months+19.32%
6 months+28.43%
Current year+41.85%
1 week 243.03
Extreme 243.03
258.78
1 month 215.73
Extreme 215.73
258.78
Current year 160.36
Extreme 160.3645
258.78
1 year 146.52
Extreme 146.5201
258.78
3 years 110.04
Extreme 110.035
268.3
5 years 110.04
Extreme 110.035
319.76
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 2022-11-13
Director of Finance/CFO 60 2025-02-28
Chief Tech/Sci/R&D Officer - 2024-10-27
Director TitleAgeSince
Director/Board Member 69 2010-03-22
Director/Board Member 77 2009-12-31
Director/Board Member 72 2019-06-18
Date Insider Type Main position Quantity % Market Cap. Importance
10/2/26 Exercice

Controller/Auditor

62 0.0000%
9/1/26 Free

General Counsel

7,405 0.0050%
8/4/26 Sell

Director

-593 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+2.29%-1.65%+68.84%+6.45% 36.08B
+6.63%+5.13%+68.86%+145.20% 1,148B
+1.53%+2.84%+47.48%+89.01% 652B
+1.68%+1.96%+29.16%+109.31% 505B
+0.73%+2.45%+54.26%+68.96% 384B
+3.83%-0.62%+69.01%+42.32% 348B
+2.38%+2.65%+34.31%+57.95% 294B
+2.26%+0.55%+3.92%+28.92% 264B
+1.97%+3.01%+57.91%+76.14% 244B
+4.03%+5.36%+39.76%+116.14% 197B
Average +2.34%+2.02%+47.35%+74.04% 407.32B
Weighted average by Cap. +2.25%+2.85%+50.38%+95.18%

Financials

2026 *2027 *
Net sales 10.4B 9.32B 8.6B 7.78B 14.55B 991B 14.78B 103B 40.92B 519B 39.05B 38.21B 1,642B 10.59B 9.49B 8.75B 7.92B 14.81B 1,009B 15.05B 104B 41.66B 528B 39.75B 38.91B 1,672B
Net income 828M 742M 685M 619M 1.16B 78.89B 1.18B 8.17B 3.26B 41.29B 3.11B 3.04B 131B 1.79B 1.61B 1.48B 1.34B 2.51B 171B 2.55B 17.67B 7.05B 89.35B 6.73B 6.58B 283B
Net Debt 5.7B 5.11B 4.71B 4.26B 7.97B 543B 8.1B 56.21B 22.43B 284B 21.4B 20.94B 900B 3.22B 2.88B 2.66B 2.41B 4.5B 306B 4.57B 31.72B 12.65B 160B 12.07B 11.82B 508B
Projected Income Statement - Annual - Biogen Inc.
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
26-10-29 $249.65 +2.29% 1,157,747
26-10-28 $244.05 -3.43% 2,493,008
26-10-27 $252.73 +0.19% 1,393,391
26-10-26 $252.26 +0.63% 958,847
26-10-23 $250.69 -1.24% 1,157,376
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Biogen Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
249.65USD
Average target price
263.29USD
Spread / Average Target
+5.46%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Biogen Inc.
  1. Stock Market
  2. Stocks
  3. BIIB Stock